FSE$LNXSY

LANXESS · Q2 2026 earnings

Q2 2026 earnings · · Investor relations

Briefing

LANXESS reported increased sales and earnings for Q2 2026 despite a weak economic environment.

LANXESS achieved sales of EUR 1.561 billion in Q2 2026, a 6.5% increase year-over-year, driven by higher volumes and prices. EBITDA pre exceptionals rose 1.3% to EUR 152 million. The company confirmed its full-year 2026 guidance and noted sequential improvements from Q1.

  • Sales reached EUR 1.561 billion, up 6.5% from EUR 1.466 billion in Q2 2025.
  • EBITDA pre exceptionals increased to EUR 152 million from EUR 150 million year-over-year.
  • Free cash flow improved to EUR 56 million in Q2 from negative EUR 29 million in Q1 2026.
  • Full-year 2026 EBITDA pre exceptionals guidance of EUR 450-550 million confirmed.

Headline financials

Total Revenue

€1.8B

No prior period
EBITDA pre exceptionals

€152M

No prior period
EBITDA margin pre exceptionals

9.7%

No prior period
Free Cash Flow

€64.6M

No prior period

Revenue by segment

LANXESS · €1.56B total across 3 segments · Q2 2026

  • Specialty Additives
    €588M—
  • Consumer Protection
    €515M—
  • Advanced Intermediates
    €456M—

Forward guidance

Full-year 2026 EBITDA pre exceptionals guidance of EUR 450 to 550 million confirmed; no further economic momentum expected by year-end.

Tailwinds

  • Cost-reduction programs expected to deliver greater contributions in H2.

Headwinds

  • No sign of sustained upturn in core markets; challenging conditions persist.

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro